Oxidants in Asthma and in Chronic Obstructive Pulmonary Disease (COPD)

E-ISSN： 1873-4286|11|16|2053-2062

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.16, 2005-06, pp. : 2053-2062

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Corticosteroid Resistance in Severe Asthma and Chronic Obstructive Pulmonary Disease (COPD)

Current Pharmaceutical Design, Vol. 16, Iss. 32, 2010-11 ,pp. : 3554-3573

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine Receptors in Chronic Obstructive Pulmonary Disease (COPD)

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 669-674

Bentham Science Publishers

Access to resources Recommend Favorite

Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease (COPD): Focus on Virus Induced Exacerbations

Current Pharmaceutical Design, Vol. 13, Iss. 1, 2007-01 ,pp. : 73-97

Bentham Science Publishers

Access to resources Recommend Favorite

Chronic obstructive pulmonary disease (COPD) may represent a serious threat

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 254, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ghrelin is promising for chronic obstructive pulmonary disease (COPD)-associated cachexia

Inpharma, Vol. 1, Iss. 1507, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite